SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Paula Scibona, Federico Angriman, Ventura Simonovich, Martina M. Heller, Waldo H. Belloso, Farmacogenómica cardiovascular, Archivos de Cardiología de México, 2014, 84, 1, 25

    CrossRef

  2. 2
    Alfi Yasmina, Anthonius de Boer, Olaf H Klungel, Vera HM Deneer, Pharmacogenomics of oral antiplatelet drugs, Pharmacogenomics, 2014, 15, 4, 509

    CrossRef

  3. 3
    Bellal Joseph, Viraj Pandit, Moutamn Sadoun, Christopher G. Larkins, Narong Kulvatunyou, Andrew Tang, Matthew Mino, Randall S. Friese, Peter Rhee, A prospective evaluation of platelet function in patients on antiplatelet therapy with traumatic intracranial hemorrhage, Journal of Trauma and Acute Care Surgery, 2013, 75, 6, 990

    CrossRef

  4. 4
    Anne Zufferey, Mark Ibberson, Jean-Luc Reny, Ioannis Xenarios, Jean-Charles Sanchez, Pierre Fontana, Unraveling modulators of platelet reactivity in cardiovascular patients using omics strategies: Towards a network biology paradigm, Translational Proteomics, 2013, 1, 1, 25

    CrossRef

  5. 5
    Sreekanth Vemulapalli, Richard C. Becker, Consultative Hemostasis and Thrombosis, 2013,

    CrossRef

  6. 6
    J. J. W. Verschuren, S. Trompet, J. A. M. Wessels, H.-J. Guchelaar, M. P. M. de Maat, M. L. Simoons, J. W. Jukema, A systematic review on pharmacogenetics in cardiovascular disease: is it ready for clinical application?, European Heart Journal, 2012, 33, 2, 165

    CrossRef

  7. 7
    André Ducati Luchessi, Vivian Nogueira Silbiger, Alvaro Cerda, Rosario Dominguez Crespo Hirata, Angel Carracedo, Maria Brion, Andres Iñiguez, Marisol Bravo, Guillermo Bastos, Amanda Guerra Morais Rego Sousa, Mario Hiroyuki Hirata, Increased clopidogrel response is associated with ABCC3 expression: A pilot study, Clinica Chimica Acta, 2012, 413, 3-4, 417

    CrossRef

  8. 8
    G. Renda, R. De Caterina, Measurements of thromboxane production and their clinical significance in coronary heart disease, Thrombosis and Haemostasis, 2012, 108, 1, 6

    CrossRef

  9. 9
    Matthew D. Linden, Huyen A. Tran, Overcoming aspirin treatment failure in diabetes, Critical Reviews in Clinical Laboratory Sciences, 2012, 49, 5-6, 183

    CrossRef

  10. 10
    Kallirroi I Kalantzi, Maria E Tsoumani, Ioannis A Goudevenos, Alexandros D Tselepis, Pharmacodynamic properties of antiplatelet agents: current knowledge and future perspectives, Expert Review of Clinical Pharmacology, 2012, 5, 3, 319

    CrossRef

  11. 11
    Marek Minarik, Marta Kopeckova, Marcus Gassman, Pavel Osmancik, Lucie Benesova, Rapid testing of clopidogrel resistance by genotyping of CYP2C19 and CYP2C9 polymorphisms using denaturing on-chip capillary electrophoresis, ELECTROPHORESIS, 2012, 33, 8
  12. 12
    Victor A. Ferraris, Jeremiah R. Brown, George J. Despotis, John W. Hammon, T. Brett Reece, Sibu P. Saha, Howard K. Song, Ellen R. Clough, Linda J. Shore-Lesserson, Lawrence T. Goodnough, C. David Mazer, Aryeh Shander, Mark Stafford-Smith, Jonathan Waters, Robert A. Baker, Timothy A. Dickinson, Daniel J. FitzGerald, Donald S. Likosky, Kenneth G. Shann, 2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines, The Annals of Thoracic Surgery, 2011, 91, 3, 944

    CrossRef

  13. 13
    Richard Hall, C. David Mazer, Antiplatelet Drugs, Anesthesia & Analgesia, 2011, 112, 2, 292

    CrossRef

  14. 14
    Mehmet Akif Topçuoglu, Ethem Murat Arsava, Hakan Ay, Antiplatelet resistance in stroke, Expert Review of Neurotherapeutics, 2011, 11, 2, 251

    CrossRef

  15. 15
    Arshad M. Bachelani, Joshua T. Bautz, Jason L. Sperry, Alain Corcos, Mazen Zenati, Timothy R. Billiar, Andrew B. Peitzman, Gary T. Marshall, Assessment of platelet transfusion for reversal of aspirin after traumatic brain injury, Surgery, 2011, 150, 4, 836

    CrossRef

  16. 16
    Bo Jin, Huan-Chun Ni, Wei Shen, Jian Li, Hai-Ming Shi, Yong Li, Cytochrome P450 2C19 polymorphism is associated with poor clinical outcomes in coronary artery disease patients treated with clopidogrel, Molecular Biology Reports, 2011, 38, 3, 1697

    CrossRef

  17. 17
    M. POSTULA, A. KAPLON-CIESLICKA, M. ROSIAK, A. KONDRACKA, A. SERAFIN, K. J. FILIPIAK, A. CZLONKOWSKI, G. OPOLSKI, P. K. JANICKI, Genetic determinants of platelet reactivity during acetylsalicylic acid therapy in diabetic patients: evaluation of 27 polymorphisms within candidate genes, Journal of Thrombosis and Haemostasis, 2011, 9, 11
  18. 18
    Nadia Paarup Dridi, Lene Holmvang, Peter Clemmensen, Oral antiplatelet agents in ischemic heart disease: a review of the latest clinical evidence, Clinical Investigation, 2011, 1, 9, 1315

    CrossRef

  19. 19
    Gyoung-Jun Rho, Woo-Ram Shin, Tae-Sik Kong, Min-Sun Kim, Chang-Ju Lee, Byung-Hee Lee, Significance of Clopidogrel Resistance Related to the Stent-Assisted Angioplasty in Patients with Atherosclerotic Cerebrovascular Disease, Journal of Korean Neurosurgical Society, 2011, 50, 1, 40

    CrossRef

  20. 20
    Tahar Chakroun, Faouzi Addad, Saloua Yacoub, Fatma Abderrezak, Gregoris T. Gerotziafas, Sadia Abdelkafi, Mohssen Hassine, Habib Gamra, Mohamed Hatmi, Ismail Elalamy, The Cyclooxygenase-1 C50T Polymorphism Is Not Associated with Aspirin Responsiveness Status in Stable Coronary Artery Disease in Tunisian Patients, Genetic Testing and Molecular Biomarkers, 2011, 15, 7-8, 513

    CrossRef

  21. You have free access to this content21
    A. D. JOHNSON, The genetics of common variation affecting platelet development, function and pharmaceutical targeting, Journal of Thrombosis and Haemostasis, 2011, 9,
  22. 22
    Tariq Ahmad, Deepak Voora, Richard C. Becker, The pharmacogenetics of antiplatelet agents: towards personalized therapy?, Nature Reviews Cardiology, 2011, 8, 10, 560

    CrossRef

  23. 23
    Haifeng M Wu, LiHui Xu, Daniel D Sedmak, Clay B Marsh, Mark W Wurster, Personalized healthcare in clotting disorders, Personalized Medicine, 2010, 7, 1, 65

    CrossRef

  24. 24
    Fatma Abderrazek, Tahar Chakroun, Faouzi Addad, Zohra Dridi, Grigoris Gerotziafas, Habib Gamra, Mohsen Hassine, Ismail Elalamy, The GPIIIa PlA polymorphism and the platelet hyperactivity in Tunisian patients with stable coronary artery disease treated with aspirin, Thrombosis Research, 2010, 125, 6, e265

    CrossRef

  25. 25
    Joseph M. Sweeny, Diana A. Gorog, Valentin Fuster, Antiplatelet drug 'resistance'. Part 1: mechanisms and clinical measurements, Nature Reviews Cardiology, 2009, 6, 4, 273

    CrossRef

  26. 26
    Bas J. M. Peters, Anthonius de Boer, Tom Schalekamp, Olaf H. Klungel, Anke-Hilse Maitland-van der Zee, Cardiovascular Pharmacogenetics,
  27. 27
    Bernard Testa, André Pannatier, Role of Phase I Metabolism in Drug Activation and Clinical Treatment Outcomes, Encyclopedia of Drug Metabolism and Interactions,